Immunogenicity of rVSV{Delta}G-ZEBOV-GP Ebola vaccination in exposed and potentially exposed persons in the Democratic Republic of the Congo [Medical Sciences]
This study examines the antibody response at 21 d and 6 mo postvaccination...
Source: Proceedings of the National Academy of Sciences - Category: Science Authors: Nicole A. Hoff, Anna Bratcher, J. Daniel Kelly, Kamy Musene, Jean Paul Kompany, Michel Kabamba, Placide Mbala-Kingebeni, Bonnie Dighero-Kemp, Gregory Kocher, Elizabeth Elliott, Cavan Reilly, Megan Halbrook, Benoit Ilunga Kebela, Adva Gadoth, Guillaume Ngo Tags: Medical Sciences Biological Sciences Source Type: research
More News: Academies | Congo Health | Ebola | Ebola Vaccine | Outbreaks | Science | Study | Vaccines